| 1. | | Not yet recruiting | Adoptive Immunotherapy and Interleukin-2 in Treating Patients With Recurrent Accelerated or Blast Phase Chronic Myelogenous Leukemia After Undergoing Allogeneic Stem Cell Transplantation
Conditions: accelerated phase chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ... |
| 2. | | Recruiting | Alemtuzumab, Total-Body Irradiation, and Fludarabine Followed By Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer |
| 3. | | Recruiting | Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
Conditions: de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; secondary myelodysplastic syndromes; ... |
| 4. | | No longer recruiting | Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
Conditions: Leukemia; Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma; kidney tumor |
| 5. | | Recruiting | Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent grade 3 follicular lymphoma |
| 6. | | No longer recruiting | Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
Conditions: disseminated neuroblastoma; Drug Toxicity; recurrent neuroblastoma |
| 7. | | Not yet recruiting | Biological Therapy in Treating Patients With Advanced Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; ... |
| 8. | | Suspended | Biological Therapy in Treating Patients With Metastatic Melanoma
Conditions: Stage IV Melanoma; Recurrent Melanoma |
| 9. | | Suspended | Biological Therapy in Treating Patients With Metastatic Melanoma
Conditions: Stage IV Melanoma; Recurrent Melanoma |
| 10. | | Suspended | Biological Therapy in Treating Patients With Metastatic Melanoma
Conditions: Stage IV Melanoma; Recurrent Melanoma |
| 11. | | No longer recruiting | Biological Therapy in Treating Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes |
| 12. | | No longer recruiting | Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia
Conditions: accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ... |
| 13. | | Recruiting | Bone Marrow Transplantation in Treating Children With Sickle Cell Disease
Condition: Sickle Cell Anemia |
| 14. | | No longer recruiting | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Conditions: Leukemia; Lymphoma; Multiple Myeloma; Eye Cancer |
| 15. | | Completed | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Conditions: Leukemia; Lymphoma; Multiple Myeloma |
| 16. | | No longer recruiting | Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome
Conditions: Refractory Anemia; refractory anemia with ringed sideroblasts; de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; ... |
| 17. | | Recruiting | Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia |
| 18. | | No longer recruiting | Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia
Conditions: accelerated phase chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia |
| 19. | | No longer recruiting | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis
Conditions: idiopathic myelofibrosis; Polycythemia Vera; Essential Thrombocythemia; Agnogenic Myeloid Metaplasia |
| 20. | | Completed | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer
Conditions: stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer |
| 21. | | Completed | Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 22. | | Completed | Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer
Conditions: Lymphoma; Leukemia |
| 23. | | Recruiting | Chemotherapy, Low-Dose Total-Body Irradiation, and Peripheral Stem Cell Transplantation Followed By Chemotherapy and Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
Conditions: chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ... |
| 24. | | No longer recruiting | Chemotherapy, Radiation Therapy, Peripheral Stem Cell Transplantation, and Immunosuppressive Therapy in Treating Patients With Cancer
Conditions: Leukemia; Renal Cell Cancer; Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma; kidney tumor |
| 25. | | Recruiting | Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
Conditions: acute leukemia; chronic myeloproliferative disorders; Graft Versus Host Disease; myelodysplastic and myeloproliferative disease |
| 26. | | No longer recruiting | Combination Chemotherapy and Peripheral Stem Cell Transplantation Followed by Interleukin-2 and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer; inflammatory breast cancer |
| 27. | | No longer recruiting | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer
Conditions: stage IIIA breast cancer; stage II breast cancer |
| 28. | | Completed | Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
Conditions: adult acute lymphoblastic leukemia in remission; childhood acute lymphoblastic leukemia in remission |
| 29. | | Completed | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma |
| 30. | | Recruiting | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Low-Dose Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
Conditions: adult acute myeloid leukemia; childhood acute myeloid leukemia |
| 31. | | No longer recruiting | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Conditions: accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ... |
| 32. | | No longer recruiting | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
Conditions: Myeloid Leukemia; Refractory Anemia |
| 33. | | No longer recruiting | Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders
Conditions: Polycythemia Vera; chronic idiopathic myelofibrosis; Essential Thrombocythemia |
| 34. | | No longer recruiting | Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma
Conditions: adult solid tumor; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; childhood solid tumor; Lymphoma |
| 35. | | No longer recruiting | Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma
Conditions: recurrent childhood rhabdomyosarcoma; adult rhabdomyosarcoma; recurrent peripheral primitive neuroectodermal tumor; ... |
| 36. | | Completed | Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma
Conditions: Stage IV Melanoma; Recurrent Melanoma |
| 37. | | Recruiting | Combining Chemotherapy, Tacrolimus, Mycophenolate Mofetil, and Radiation Therapy with Donor Bone Marrow Transplantation in Treating Patients with Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ... |
| 38. | | Recruiting | Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Allogeneic Transplantation
Conditions: Cancer; Graft Versus Host Disease |
| 39. | | Recruiting | Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
Conditions: adult acute lymphoblastic leukemia in remission; childhood acute lymphoblastic leukemia in remission |
| 40. | | Recruiting | Donor Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ... |
| 41. | | No longer recruiting | Donor Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome and Myeloproliferative Disorders
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ... |
| 42. | | No longer recruiting | Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia
Conditions: adult acute lymphoblastic leukemia in remission; recurrent adult acute myeloid leukemia; acute undifferentiated leukemia; ... |
| 43. | | Recruiting | Fludarabine and Total-Body Irradiation Followed By Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate
Conditions: recurrent childhood acute lymphoblastic leukemia; recurrent adult acute lymphoblastic leukemia; blastic phase chronic myelogenous leukemia; ... |
| 44. | | Recruiting | Fludarabine, Low-Dose Total-Body Irradiation, Donor Stem Cell Transplantation, and Immunosuppression Therapy in Treating Patients Who Have Fanconi’s Anemia
Conditions: Fanconi's Anemia; adult acute myeloid leukemia; childhood acute myeloid leukemia; Graft Versus Host Disease; Myelodysplastic Syndromes |
| 45. | | No longer recruiting | Fludarabine, Total-body Irradiation, Donor Peripheral Stem Cell Transplantation, and Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
Conditions: Leukemia; Renal Cell Cancer; Lymphoma; Eye Cancer; Kidney Cancer |
| 46. | | Recruiting | Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia |
| 47. | | No longer recruiting | Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; recurrent adult acute myeloid leukemia; ... |
| 48. | | Completed | Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation
Conditions: recurrent adult non-Hodgkin's lymphoma; recurrent childhood acute lymphoblastic leukemia; recurrent adult acute myeloid leukemia; ... |
| 49. | | No longer recruiting | High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
Conditions: stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; refractory chronic lymphocytic leukemia; ... |
| 50. | | No longer recruiting | Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone
Conditions: recurrent childhood rhabdomyosarcoma; recurrent adult soft tissue sarcoma; adult rhabdomyosarcoma; stage IVB adult soft tissue sarcoma; ... |
